Shoulder arthroplasty has undergone a transformative phase, transitioning from simple bone replacement to complex, patient-specific biomechanical reconstruction. As the global population ages and the incidence of rotator cuff arthropathy and complex fractures rises, the demand for high-quality, reliable, and cost-effective orthopedic implants is at an all-time high. China has emerged as the global epicenter for medical device manufacturing, combining high-precision CNC capabilities with rigorous quality control standards like ISO 13485.
The manufacturing landscape for orthopedic implants requires more than just machinery; it requires deep clinical insight. Our manufacturing model integrates R&D directly with clinical feedback loops. Unlike generic manufacturers, we act as a specialized partner in the medical device value chain. By adhering to international regulatory standards (CE, FDA), we ensure that our wholesale orthopedic components bridge the gap between affordability and uncompromising clinical performance.
The future of shoulder arthroplasty lies in biocompatibility and smart integration. Our current technical roadmap focuses on:
We are dedicated to the research, development, production, and sales of orthopedic implants and tools. In the continuous process of design updates, we strive for excellence, meticulously crafting each product.
Quality Control Philosophy: Quality and integrity first, striving for excellence, and pursuing the highest standards. A professional R&D team and long-term technical exchanges with leading hospital experts ensure that our products function to their fullest potential. Our factory has passed ISO 9001 and ISO 13485 certifications. Our products exceed all international quality and safety standards, including CE and FDA certifications. For many years, our products have been exported to more than 70 countries and regions in Europe, America, Africa, and Southeast Asia.
A: We adhere to strict ISO 13485 management systems. Every product batch undergoes rigorous testing, including leakage current testing, mechanical stress analysis, and biocompatibility verification, ensuring full alignment with CE and FDA requirements.
A: Absolutely. Our R&D team collaborates with leading surgeons globally. We provide full-cycle support from prototyping (utilizing our CNC and vacuum systems) to mass production and regulatory filing support.
A: Depending on the customization complexity, our streamlined production line enables us to maintain one of the most efficient lead times in the industry, typically ranging from 4 to 8 weeks for bulk orders.
Daher Orthopedic Implants
